Home MarketFortis Healthcare Ltd.

Fortis Healthcare Ltd. Stock Info: As on 2017-07-26 15:59:54

Nse

166.25

-2.40(-1.42%)
Change%
52 Week Range
142.15
17.00
228.95
3.00
Open169.80
Day's Range151.79 - 185.52
Value Traded (in ₹ Cr.) 63.07

Bse

166.15

-2.60(-1.54%)
Change %
52 Week Range
142.60
9.00
230.90
3.00
Open169.45
Day's Range151.88 - 185.63
Value Traded (in ₹ Cr.) 9.40

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 222,762,120.00 42.96%
Mutual Funds/UTI 29,200,572.00 5.63%
FII 169,300,449.00 32.65%
Employee 0.00 0.00%
Public 57,897,660.00 11.17%
Government 0.00 0.00%
Others 37,600,558.00 7.25%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 13.29
Basic EPS (Rs.) -1.59
Cash EPS -1.04
BVPerShare Excl 77.91
Operating Revenue 13.21
PBDITPerShare 0.63
Dividend 0.00
NPPerShare -1.59
Current Ratio 1.85
Quick Ratio 1.84
PriceToBV 2.25
Earnings -0.01
PBDIT Margin 4.80
PBT Margin -12.01
NP Margin -12.01
Return On Assets -1.49
Retention Ratios 0.00
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 758.83
Total Expenses 817.00
EBITDA 29.39
PBT -73.51
PAT -73.51
Net Income -73.51
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 376.34
Total Expenses 367.99
EBITDA -5.60
PBT -30.78
PAT -30.78
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Parameter Mar-16 (₹ Cr.) 6M % change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Company Curr Price Prev. Close Change% W's Low/High

Apollo Hospitals Enterprise Ltd.

1292.75 1294.3 -0.12
1230.051312

Dr. Lal Pathlabs Ltd.

838.35 839.35 -0.12
834858

Healthcare Global Enterprises Ltd.

271.95 270.5 0.54
263.3275

Indraprastha Medical Corporation Ltd.

57.85 57.95 -0.17
55.2560.85

Kovai Medical Center and Hospital Ltd.

641.65 624.85 2.68
629.9649.9

Lotus Eye Hospital and Institute Ltd.

40.7 39.35 3.43
3640.9

Marico Kaya Enterprises Ltd.

1547.05 1582.55 -2.24
1535.051589
Company Curr Price Prev. Close Change% W's Low/High

ADS Diagnostic Ltd.

11.34 10.8 0
11.3411.34

Apollo Hospitals Enterprise Ltd.

1289.95 1288.55 0.11
1226.41310

Birla Pacific Medspa Ltd.

0.28 0.27 0
0.270.28

CDR Health Care Ltd.

7.58 2.6 0
7.227.58

Chennai Meenakshi Multispeciality Hospital Ltd.

11.4 11.5 -0.87
11.411.4

Dhanvantri Jeevan Rekha Ltd.

40 38.4 4.17
36.540.3

Dolphin Medical Services Ltd.

1.38 1.45 -4.83
1.251.52
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities -693.61
Cash from investing activities 379.12
Cash from financing activities 317.58
Net change in cash 3.09

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
Birla Sun Life Balanced 95 Fund 0.66%
JM Arbitrage Advantage Fund 2.44%
UTI Spread Fund 3.46%
Kotak Equity Arbitrage Fund - Regular Plan 0.51%
Kotak Equity Savings Fund - Regular Plan 3.97%
ICICI Prudential Equity - Arbitrage Fund 0.36%

Adlabs Entertainment posts Q1 net loss of Rs 22.51 cr

Net revenue of the company rose marginally by 4.24 per cent at Rs 86.62 crore for the quarter ended June 30, 2017 as against Rs 83.10 crore in the corresponding period last year. During Apr-Jun quarter, operating expenses dropped by 2.39 per cent to Rs 54.39 crore from Rs 55.72 in year ago period. Other Income dipped by 33.33 per cent at Rs 0.16 crore versus (Jun'16 Rs 0.24 crore). Operating Profit surged by 6.62 per cent to Rs 32.23 crore as against Rs 30.23 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 2.25 per cent in Jun quarter. Interest grew by 9.52 per cent y-o-y to Rs 31.97 crore. On the standalone basis, Net loss during the quarter stood at Rs 22.51 crore as compared to net loss of Rs 19.23 crore in the previous year quarter.

26-07-2017 17:45

NCLT appoints IRP for Nagarjuna Oils Corporation

Nagarjuna Oil Refinery Ltd (NOCL) today said the National Company Law Tribunal (NCLT), Chennai, has appointed an Insolvency Resolution Professional (IRP) for NOCL. The NCLT passed the order yesterday based on an application filed by the creditors, it said. We have to inform you that under the Insolvency and Bankruptcy Code, 2016, an Insolvency Resolution Professional (IRP) has been appointed by National Company Law Tribunal, on July 25, 2017 for Nagarjuna Oil Corporation Ltd based on an application filed by one of its creditors, NORL said in a filing with bourses. NORL holds 46.78 per cent of the equity share capital in NOCL, which is involved in setting-up a refinery at Cuddalore in Tamil Nadu. The company shall be entitled to take any proposal before the IRP during the period of six months or such extension that may be permitted in the event an investor is identified to take the project forward, the filing further said. Meanwhile, shares of the company closed trading at Rs 4.55 apiece, up 8.59 per cent from the previous close on BSE.

26-07-2017 17:29

Ion Exchange (India) Q1 net profit up 8.32% at Rs 7.29 cr

Net revenue of the company rose moderately by 9.56 per cent at Rs 208.05 crore for the quarter ended June 30, 2017 as against Rs 189.90 crore in the corresponding period last year. During Apr-Jun quarter, operating expenses increased by 10.02 per cent to Rs 196.18 crore from Rs 178.32 in year ago period. Other Income grew by 59.55 per cent at Rs 5.68 crore versus (Jun'16 Rs 3.56 crore). Operating Profit slipped by 0.92 per cent to Rs 11.87 crore as against Rs 11.98 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 9.51 per cent in Jun quarter. Interest grew by 20.75 per cent y-o-y to Rs 3.20 crore, while Taxation increased by 6.69 per cent at Rs 3.83 crore (Jun'16 Rs 3.59 crore). On the standalone basis, Net Profit during the quarter increased by 8.32 per cent to Rs 7.29 crore from Rs 6.73 crore in the previous year quarter.

26-07-2017 17:20

G G Automotive Gears Q1 net profit zooms 106.67%

Net revenue of the company rose substantially by 45.42 per cent at Rs 8.10 crore for the quarter ended June 30, 2017 as against Rs 5.57 crore in the corresponding period last year. During Apr-Jun quarter, operating expenses increased by 42.25 per cent to Rs 7.07 crore from Rs 4.97 in year ago period. Other Income grew by 0.00 per cent at Rs 0.01 crore versus (Jun'16 Rs 0.00 crore). Operating Profit surged by 54.55 per cent to Rs 1.02 crore as against Rs 0.66 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 6.94 per cent in Jun quarter. Interest grew by 73.33 per cent y-o-y to Rs 0.26 crore, while Taxation increased by 100.00 per cent at Rs 0.06 crore (Jun'16 Rs 0.03 crore). On the standalone basis, Net Profit during the quarter increased by 106.67 per cent to Rs 0.31 crore from Rs 0.15 crore in the previous year quarter.

26-07-2017 17:15

Agro Tech Foods Ltd. Q1 net profit up 5.86% at Rs 6.50 cr

Net revenue of the company declined marginally by 1.80 per cent at Rs 187.16 crore for the quarter ended June 30, 2017 as against Rs 190.60 crore in the corresponding period last year. During Apr-Jun quarter, operating expenses dropped by 1.64 per cent to Rs 173.19 crore from Rs 176.08 in year ago period. Other Income dipped by 50.00 per cent at Rs 0.02 crore versus (Jun'16 Rs 0.04 crore). Operating Profit slipped by 3.31 per cent to Rs 14.61 crore as against Rs 15.11 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 1.51 per cent in Jun quarter. Interest declined by 88.51 per cent y-o-y to Rs 0.20 crore, while Taxation increased by 19.14 per cent at Rs 3.61 crore (Jun'16 Rs 3.03 crore). On the standalone basis, Net Profit during the quarter increased by 5.86 per cent to Rs 6.50 crore from Rs 6.14 crore in the previous year quarter.

26-07-2017 17:10

Fortis Healthcare - Shareholding for the Period Ended June 30, 2017

Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017.

10-Jul-2017 03:20 PM

Fortis Healthcare - Statement Of Investors Complaints For The Quarter Ended On June, 2017.

Please find the Statement giving the number of investor complaints pending at the begning of the quarter, those received during the quarter, disposed of during the quarter and those remaining unresolved at the end of the quarter ended June 30, 2017, as received from the registrar and Transfer Agent, pursuant to Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015.

10-Jul-2017 03:14 PM

RBI allows FIIs to invest up to 74% in Fortis Healthcare

The Reserve Bank of India on Friday allowed the Foreign Institutional Investors (FIIs) to invest up to 74 per cent under portfolio investment scheme in Fortis Healthcare. “The investment limit under portfolio investment scheme was fixed at 24 per cent earlier,” RBI said in a notification. The apex bank said that Fortis Healthcare Limited has passed necessary resolutions of its Board of Directors and General Body as required under the FEMA 1999 and the regulations framed thereunder. Further, owing to the above increase in FIIs investment limit, it is notified that the aggregate shareholding by FIIs in Fortis Healthcare Limited has gone below the prescribed investment limit for the company. Hence, the restrictions placed on the purchase of shares by FIIs of the above company are withdrawn with immediate effect, it added.

10-Jul-2017 08:55 AM

Fortis Healthcare - Updates

In continuation to our letter No. FHL/SEC/STEX/RR/2017-18 dated May 25, 2017, it is hereby informed that the Company has received necessary approvals of the shareholders and Reserve Bank of India for enhancement of the ceiling limit on total holdings of FII/SEBI approved sub-accounts of FIIs, FPIs, QFIs, Non Resident Indians (NRIs) and Person of Indian Origin (PIO) under the Portfolio Investment Scheme upto 74% of the paid-up equity capital of the Company.

The letter received from RBI is attached herewith for your ready reference.

This is for your kind information and records purposes.

07-Jul-2017 06:31 PM

Fortis Healthcare - Updates


This is to inform that the Board of Directors have today, approved a proposal to enhance the ceiling limit on total holdings of FII/SEBI approved sub-accounts of FIIs, FPIs, QFIs, Non Resident Indians (NRIs) and Person of Indian Origin (PIO) under the Portfolio Investment Scheme upto 74% of the paid-up equity capital of the Company.

The said increase is subject to the approval of the shareholders and such statutory/ regulatory approvals as may be necessary in this regard.

Further, the Board has also approved the Notice of Postal Ballot along with Appointment of scrutinizer for the same.

This is for your kind information and records purposes.

07-Jul-2017 05:35 PM

Fortis Healthcare - Shareholding for the Period Ended June 30, 2017

Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017.

10-Jul-2017 03:20 PM

Fortis Healthcare - Statement Of Investors Complaints For The Quarter Ended On June, 2017.

Please find the Statement giving the number of investor complaints pending at the begning of the quarter, those received during the quarter, disposed of during the quarter and those remaining unresolved at the end of the quarter ended June 30, 2017, as received from the registrar and Transfer Agent, pursuant to Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015.

10-Jul-2017 03:14 PM

Fortis Healthcare - Updates

In continuation to our letter No. FHL/SEC/STEX/RR/2017-18 dated May 25, 2017, it is hereby informed that the Company has received necessary approvals of the shareholders and Reserve Bank of India for enhancement of the ceiling limit on total holdings of FII/SEBI approved sub-accounts of FIIs, FPIs, QFIs, Non Resident Indians (NRIs) and Person of Indian Origin (PIO) under the Portfolio Investment Scheme upto 74% of the paid-up equity capital of the Company.

The letter received from RBI is attached herewith for your ready reference.

This is for your kind information and records purposes.

07-Jul-2017 06:31 PM

Corporate Details

About Management

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress.

Registered Office

Fortis-Escorts Hospital: 2nd Floor, Coronation Hospital, Curzon Road,

,,,      ,

Registrar Details

Karvy Computershare Private Ltd.